TEST:

Immunoscore®

Immunoscore® is a test predicting the risk of relapse of patients with localized CC to help guiding treatment strategies. By evaluating the immune reaction at the tumor site, it provides independent and superior prognostic value to usual risk factors. Immunoscore® surpasses TNM for prediction of tumor recurrence and survival in CRC patients.